PROJECT MANAGEMENT

A presentation on the current project trends in Pfizer.

WHY DOES PFIZER EXIST?We exist due to a single goal: Your Health. That's why we're dedicated to developing new, safe medicines to prevent and treat the world's most serious diseases. And why we are making them available to the people who need them most. We believe that from progress comes hope and the promise of a healthier world. 

HOW DO WE DO WHAT WE BELIEVE IN?

At Pfizer, we strive to positively impact the health of the people around the world. Our philanthropy is focused on investing the full range of the company’s resources- People, skills, expertise and funding- to broaden access to medicines and strengthen healthcare delivery for undeserved people around the world.Improving access to medicines and health services.Expanding healthcare worker training and patient education on diseases.Strengthening the capacity of healthcare organizations to support diagnosis and care.Advocating and sharing best practices to improve healthcare for the under privileged people through direct engagements with NGOs and other government plans.

WHAT DO WE DO TO CHANGE THE WORLD? Right from the Civil War in 1862 to now. Pfizer has been innovating in the field of pharmaceuticals- be it the first company to produce citric acid on a large scale to the latest launch of a biosimilars in Arthritis. We have been in the healthcare industry when the people needed us the most. We gave them penicillin then, and now, we’re the 3rd biggest company to provide medicines all over the world. We also treat people around the globe with our excellent employees and medical devices.

LET’S BUILD SOMETHING NEW In the making of a new molecule, the first step is to develop a project that gives quicker outcome, thus providing a benefit for lower cost, in a more predictable way. To put it more properly, we can say.. “You can miss expectations with a below

average execution of an excellent strategy, but you can exceed

expectations with excellent execution of an average strategy”

DEMANDS AND STRATEGY The initiation of a project is done by understanding the necessities of the current pharmaceutical market and then coming up with a plan to provide the world with a cure.

Once a problem is apprehended, the organization has to strategize a new project which would help the innovation of a new molecule. The strategy is planned out on various factors.

MANPOWER MACHINERY RISKS

RESOURCES FINANCES

PLANNING THE PROJECTFormation of Team with a Leader

Scope of the ProjectWork Structure

Time/Cost Trade-OffsStakeholder Planning

SCHEDULING THE PROJECT PROGRAMME

DAY 1

DAY 1

DAY 2

DAY 2 DAY 3

INITIATION

RESULT

AGGREGATION OF RESOURCES The resources at hand must be monitored and used wisely. Manpower and Machinery available are inversely proportional to the amount of time required to complete the project.

IDENTIFYING THE RISKSProject Risks

Schedule

Poor Estimatio

n

Insufficient

Resources

Requirement

Uncertainties

Cost

Lack of Funding Inflation Labour

Costs

Scope

New Tests

New Technolo

gy

Regulatory

Changes

PROJECT COMMUNICATION PLAN

ProjectManag

er

Supervisor

Team

Stakeholder

Team

PROJECT IMPLEMENTATIONProject Implementation is the stage in which the project turns into reality in order to produce “Deliverables”

Deliverables include Products, Services and Project Management documents

The steps to produce deliverables depend on the type of project

PROJECT IMPLEMENTATIONBasic Requirements

• A project plan.• Financial, Material and

Human resources.• Project Manager

Basic Steps

• Installation of systems and Trainings

• Project monitoring with regard to cost, value of work and time.

• Effective change control.• Updating of project schedule

after slippages in time and cost.

• Coordination with the head office, suppliers, contractors and project members.

• Documentation

REVIEW OF THE COMPLETED PROJECT

A project is completed when all objectives are met

Reporting

Closure Phase

Review

Gate

Project Managers Access performance Areas of deviation Possible problems

Final Deliverables

CLOSURE PHASEHanding over the project reports

Releasing the final deliverables/ Launching the product in the market

Post market surveillance (Evaluation)

Release of project resources

Terminating contracts and doing final payments if any

Communicating project closure to all stakeholders

CHALLENGES IN A PROJECTThe industry average to bring a new drug to market is 15 years. Each year of discovery and development entails billions of dollars in research and testing. Pharmaceutical companies like Pfizer must make informed decisions about which prospective drugs show the most promise, and focus their resources accordingly, to be competitive. We present you a case on the challenges faced by Pfizer Australia and how they came to a solution.

DISCRETIONARY SPENDS: MAJOR ACHIEVEMENT IN AUSTRALIAOne of the nations leading health care partners. Employees more than 1,100 staff in Australia.Australia’s most innovative and valued health care committee.

THE OBSTACLESLoss of patent production of key products.Change in strategy was the need of the hour.Excess of 100 projects. No clear idea of what the project was.“Accidental Project Managers”. Lack of consistency. Multiple projects being run with conflicting or impacting objectives.

TO TACKLE THOSE CHALLENGESAdaptra was engaged to review its Project management and execution capabilities.Lead to the formation of Project Management Organization, which was responsible of the following:•Return on discretionary spend.•Increase decision-making capabilities. •Improve cross-functional collaboration.•Organisational cultural change.•Increase employee satisfaction.

WE’VE MADE IT!Establishment of the PMO within six months.Reduce the 100+ projects to a prioritized and manageable ‘Top 40’.Optimized the use of limited resources.Managers are focused on doing ‘the right things right’.Established a project management community.

“The PMO provided people with the skills, confidence and advice to help our managers execute their projects – I can’t live without our PMO now, and Adaptra have made that possible.”

-Jane FrostDirector, Pfizer Australia

CURRENT PROJECT TRENDSPfizer is prioritizing its research and development efforts in areas with the greatest scientific and commercial promise: immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain, and vaccines. Through major research efforts across multiple modalities — including small molecules, biologics and vaccines — Pfizer is developing the medical solutions that will matter most to the people we serve. Specialized efforts in biosimilars as well as rare diseases also illustrate our dedication to developing and delivering innovative medicines and vaccines that will benefit patients around the world.

PRODUCT PIPELINE

PHARMACEUTICAL INDUSTRY PROJECTSA company grows by the growth of its employees, as well as their assets. There is a serious need of expansion of the research and the manufacturing facilities if a company wants to grow in reputation and market value. The recent development in the facilities of Pfizer include: Biotechnology Centre at China for the development of biosimilars in Asia.Pfizer Biologic’s Clinical Manufacturing facility, USA.Pfizer Bulk Pharmaceutical Factory, Singapore.Pfizer Biotechnology Campus, Ireland.

THANK YOU !HAVE A NICE EVENING.